Aytu Bioscience, Inc reported raising $11.8 Million in an initial SEC Form D filing, from an offering of $11.8 Million
Amount Raised
$11.8 Million
Round Type
Venture
Quick answer
Aytu Biopharma, Inc raised $11.8 Million in a funding round, dated August 24, 2017. Aytu Biopharma, Inc is based in Denver, Colorado, United States.
- How much did Aytu Biopharma, Inc raise?
- Aytu Biopharma, Inc raised $11.8 Million in a funding round on August 24, 2017.
- What does Aytu Biopharma, Inc do?
- Aytu BioScience is a specialty healthcare company focused on developing treatments for urological and related conditions.
- Where is Aytu Biopharma, Inc based and how big is it?
- Aytu Biopharma, Inc is based in Denver, Colorado, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Aytu Biopharma, Inc that raised within 45 days of this round, from Fundz verified event records.
- CALCIVIS LTD raised $1.3M (Seed) on October 6, 2017.
- Harmony Biosciences II, Inc. raised $270M on October 6, 2017.
- Recursion Pharmaceuticals raised $56M on October 6, 2017.
- Zenflow raised $11M on October 6, 2017.
- DAV Acquisition Corp. raised $500K (Seed) on October 5, 2017.
- HARBOR MEDTECH, INC. raised $250K on October 5, 2017.
Who to call at Aytu Biopharma, Inc, and when
A new round usually means Aytu Biopharma, Inc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aytu Biopharma, Inc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aytu Biopharma, Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aytu Biopharma, Inc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aytu Biopharma, Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Aytu Biopharma, Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.